Menu Search
Equities

Bellevue Healthcare Trust PLC

67B:FRA

Bellevue Healthcare Trust PLC

Actions
  • Price (EUR)1.60
  • Today's Change0.03 / 1.91%
  • Shares traded--
  • 1 Year change+11.11%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 20:49 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Bellevue Healthcare Trust plc is a United Kingdom-based investment trust. The investment objective of the Company is to provide Shareholders with capital growth and income over the long term, through investment in listed or quoted global healthcare companies. The Company invests in a concentrated portfolio of listed or quoted equities in the global healthcare industry. The Company may also invest in American Depositary Receipts (ADRs), or convertible instruments issued by such companies and may invest in, or underwrite, future equity issues by such companies. Its portfolio includes Dental, Diagnostics, Diversified Therapeutics, Focused Therapeutics, Healthcare information technology, Healthcare Technology, Managed Care, Med-Tech, and Services. The Company's investment manager is Bellevue Asset Management (UK) Limited.

  • Revenue in GBP (TTM)-19.04m
  • Net income in GBP-30.45m
  • Incorporated2016
  • Employees0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.